Over the past five years, health experts in the United States and Europe have alerted that birth control pills like Yaz and Yasmin could increase the risk of blood clots. What resulted was thousands of women coming forward with injuries, seeking help since they were not properly warned of these risks by the maker of the drugs, Bayer.
With reports that the number of lawsuits was reaching above 10,000 and contunied evidence stacked against Bayer, the company announced in 2012 that they would begin settling many of the cases involving blood clots.
Early reports from court officers estimated that the settlement of Yaz lawsuits might end near summer of 2013, which left many victims worried that they wouldn’t receive adequate compensation for their injuries.
However, information disclosed by Bayer in their latest financial reports now indicates the company has reserved sufficient funds and intends to continue the settlements.
According to Bayer’s 2012 annual report released in February, the company has already spent around $1 billion to settle approximately 4,800 Yaz lawsuits*. However, they admitted they face claims from as many as 13,000 additional parties.
Bayer informed shareholders that they have reserved nearly $500 million more and will continue to evaluate new claims on a case-by-case basis.
Although Yaz remains available in the United States, enough women have filed a Yaz lawsuit that the cases were moved to a special federal MDL court in Illinois. Elsewhere, cases have begun in France, Switzerland and Canada.
The report that Bayer will continue to compensate those with blood clot injuries is encouraging for anyone affected has not yet filed a claim. Patients are urged to speak with a lawyer regardless of the time elapsed since they had an injury. However, the time to take action is still limited.
Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin could be eligible for compensation.
Due to the specialized nature of the federal drug injury claims, DrugRisk cautions that patients should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.
Contact us today for more information on the research, side effects and litigation news related to Yaz, or to speak with a lawyer.
*Bayer 2012 Annual Report, Consolidated Financial Statement, Legal Notes, February 28, 2013